Svb Wealth LLC Kal Vista Pharmaceuticals, Inc. Transaction History
Svb Wealth LLC
- $1.85 Billion
- Q2 2025
Shares
2 transactions
Others Institutions Holding KALV
# of Institutions
146Shares Held
54.1MCall Options Held
986KPut Options Held
90.1K-
Vr Adviser, LLC New York, NY6.73MShares$82.4 Million15.07% of portfolio
-
Suvretta Capital Management, LLC New York, NY4.96MShares$60.7 Million1.93% of portfolio
-
Tang Capital Management LLC San Diego, CA4.94MShares$60.5 Million3.35% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA4.89MShares$59.9 Million2.92% of portfolio
-
Vestal Point Capital, LP New York, NY4.68MShares$57.3 Million2.78% of portfolio
About KalVista Pharmaceuticals, Inc.
- Ticker KALV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 24,602,000
- Market Cap $301M
- Description
- KalVista Pharmaceuticals, Inc., a clinical stage pharmaceutical company, discovers, develops, and commercializes small molecule protease inhibitors for diseases with unmet needs. The company's product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angioedema (HAE) and diabetic macular edema (DME); and oral p...